Detalhe da pesquisa
1.
Might simplification of transcatheter aortic valve implantation reduce the burden on hospital resources?
Eur Heart J Suppl
; 24(Suppl B): B28-B35, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35370505
2.
Nurse-led sedation for transfemoral transcatheter aortic valve implantation seems safe for a selected patient population.
Eur Heart J Suppl
; 24(Suppl B): B23-B27, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35370506
3.
Bioresorbable scaffold implantation in STEMI patients: 5 years imaging subanalysis of PRAGUE-19 study.
J Transl Med
; 18(1): 33, 2020 01 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32000796
4.
Immune-inflammatory response after bioresorbable vascular scaffold implantation in patients with acute myocardial infarction with ST elevation in a long-term perspective.
Heart Vessels
; 34(4): 557-563, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30315494
5.
Optical coherence tomography in STEMI with bioresorbable scaffold: possible cause of coronary flow impairment? A sub-study from the Prague 19 trial.
Heart Vessels
; 33(11): 1282-1287, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29777297
6.
Neointimal coverage and late apposition of everolimus-eluting bioresorbable scaffolds implanted in the acute phase of myocardial infarction: OCT data from the PRAGUE-19 study.
Heart Vessels
; 31(6): 841-5, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25896128
7.
Bioresorbable vascular scaffolds in acute ST-segment elevation myocardial infarction: a prospective multicentre study 'Prague 19'.
Eur Heart J
; 35(12): 787-94, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24419808
8.
[Fully absorbable drug eluting coronary stent: where do we stand in 2014?]. / Plne vstrebatelný lékový koronární stent: kde jsme v roce 2014?
Vnitr Lek
; 60(4): 322-6, 2014 Apr.
Artigo
em Tcheco
| MEDLINE | ID: mdl-24985992
9.
ST elevation myocardial infarction treated with bioresorbable vascular scaffold: rationale and first cases.
Eur Heart J
; 34(27): 2073, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23729688
10.
Takotsubo Cardiomyopathy: One More Angiographic Evidence of Microvascular Dysfunction.
Biomed Res Int
; 2018: 5281485, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29725598
11.
Invasive Hemodynamic Assessment of Cardiac Output State after MitraClip Therapy in Nonanaesthetized Patients with Functional Mitral Regurgitation.
Biomed Res Int
; 2016: 6296972, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-28058260
12.
Long-term follow-up after bioresorbable vascular scaffold implantation in STEMI patients: PRAGUE-19 study update.
EuroIntervention
; 12(1): 23-9, 2016 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-27173858
13.
One-year coronary bypass graft patency: a randomized comparison between off-pump and on-pump surgery angiographic results of the PRAGUE-4 trial.
Circulation
; 110(22): 3418-23, 2004 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-15557371
14.
One-Year Clinical and Computed Tomography Angiographic Outcomes After Bioresorbable Vascular Scaffold Implantation During Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: The PRAGUE-19 Study.
Circ Cardiovasc Interv
; 8(12): e002933, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26628591
15.
Shock index: a simple clinical parameter for quick mortality risk assessment in acute myocardial infarction.
Can J Cardiol
; 27(6): 739-42, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21944278
16.
Long-term outcomes of patients with acute myocardial infarction presenting to hospitals without catheterization laboratory and randomized to immediate thrombolysis or interhospital transport for primary percutaneous coronary intervention. Five years' follow-up of the PRAGUE-2 Trial.
Eur Heart J
; 28(6): 679-84, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17298968